search
Back to results

WithHolding Enteral Feeds Around Blood Transfusion (International) (WHEAT)

Primary Purpose

Necrotizing Enterocolitis

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Withholding feeds around transfusion
Continued feeds around transfusion
Sponsored by
IWK Health Centre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Necrotizing Enterocolitis focused on measuring Comparative Effectiveness Trial, Necrotizing Enterocolitis, Premature Infants, Blood Transfusion, Withholding enteral feeds

Eligibility Criteria

undefined - 30 Weeks (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

1. Preterm birth at <30+0 gestational weeks + days

Exclusion Criteria:

  1. Parent(s) opt-out of trial participation.
  2. Packed red cell transfusion with concurrent enteral feeds prior to enrolment. (Infants who have received a packed red cell transfusion while nil-by-mouth are eligible; buccal colostrum will not be counted as enteral feeding).
  3. Infants where enteral feeding is contraindicated in the first 7 days after birth [e.g. Major congenital abnormality of the gastrointestinal tract (GIT)].
  4. Previous episode of NEC or spontaneous intestinal perforation (SIP) prior to first packed cell transfusion.

Sites / Locations

  • IWK HealthRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Withholding feeds around transfusion

Continuing feeds around transfusion

Arm Description

All enteral feeds will be discontinued (the infant will be placed nil by mouth) for 4 hours prior to packed red cell transfusion, during the transfusion and until 4 hours post transfusion. During this period, hydration and blood glucose will be maintained according to local practice, commonly by providing parenteral nutrition or intravenous dextrose. Four hours after the red cell transfusion has finished, feeds will be recommenced to how they were being received prior to the decision to transfuse. This duration of withholding feeds will follow the approach used in other trials and observational studies, and identified as the most acceptable in a survey of UK neonatal units. It gives time for milk in the small bowel to transit into the large bowel before the transfusion and for the circulation to stabilize after the transfusion before milk feeds given into the stomach pass through into the small intestine.

Enteral feeds will continue to be given prior, during and after the packed red cell transfusion, in the manner in which they were being given prior to the decision to transfuse. Infants will remain allocated to the same care pathway until 34(+6) weeks(+days) gestational age.

Outcomes

Primary Outcome Measures

NEC Stage II
NEC stage II or more after the first transfusion (modified Bell staging criteria) - Clinical signs and symptoms plus pneumatosis or portal/hepatic air diagnosed by x-ray or other imaging techniques

Secondary Outcome Measures

Severe NEC
Histologically or surgically confirmed or recorded on the death certificate. These infants will be identified as described in Battersby et al. which will include infants recorded as being transferred for surgery.
Death
All-cause mortality
Late onset sepsis
Culture positive sepsis, onset after 72 hours of life
Number of days with a central venous line in situ
Number of days with a central venous line in situ
Number of central line associated bloodstream infections
Includes laboratory-confirmed bloodstream infection and clinical sepsis
Duration of any parenteral nutrition in days
Duration of any parenteral nutrition in days
Growth
Weight and head circumference z score.
Spontaneous Intestinal Perforation
Histologically or surgically confirmed or recorded in the death certificate.
Duration of hospital stay
Total duration of neonatal care in days including all levels of care (intensive care, high dependency care, special care and ordinary care)
Bronchopulmonary Dysplasia (BPD)/Chronic Lung Disease
Requiring respiratory support at 36 weeks gestation
Retinopathy of prematurity (ROP)
ROP requiring treatment
Severe Brain Injury
Intraventricular haemorrhage (IVH) grade 3 or 4 or cystic periventricular leukomalacia (PVL)

Full Information

First Posted
December 8, 2021
Last Updated
September 26, 2023
Sponsor
IWK Health Centre
Collaborators
Canadian Institutes of Health Research (CIHR), Imperial College London
search

1. Study Identification

Unique Protocol Identification Number
NCT05213806
Brief Title
WithHolding Enteral Feeds Around Blood Transfusion (International)
Acronym
WHEAT
Official Title
The WHEAT International Trial: WithHolding Enteral Feeds Around Red Cell Transfusion to Prevent Necrotizing Enterocolitis in Preterm Neonates: an International, Multi-centre, Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 28, 2022 (Actual)
Primary Completion Date
December 31, 2025 (Anticipated)
Study Completion Date
December 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
IWK Health Centre
Collaborators
Canadian Institutes of Health Research (CIHR), Imperial College London

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The WHEAT International trial is a comparative effectiveness trial exploring whether withholding enteral feeds around the time of blood transfusion in very premature infants (<30 weeks) will reduce the occurrence of Necrotizing Enterocolitis (NEC). Currently both continued feeding and withholding feeding are approved care practices. The current study will randomize infants from Neonatal Intensive Care Units (NICUs) across Canada and the United Kingdom (UK) into one of the two care approaches (withholding or continued feeds) to determine if any significant outcomes are found.
Detailed Description
BACKGROUND: Necrotizing enterocolitis (NEC) is a devastating disease that affects mostly the intestine of premature infants. The wall of the intestine is invaded by bacteria, which cause local infection and inflammation that can ultimately destroy the wall of the bowel (intestine). NEC is among the most potentially devastating neonatal diseases and has a mortality of up to 33%, the most severe form (requiring surgery or resulting in death) affects about 5% of infants born at less than 30 gestational weeks; survivors are at high risk of long-term health and developmental problems. Prevention of NEC has been identified as one of the most important research uncertainties in the field of preterm birth. A temporal association between red cell transfusion and the subsequent development of the disease is well described. This 'transfusion-associated NEC' may also be more severe with higher mortality. Very preterm or extremely low birth weight infants are among the most frequently transfused patients: between 56% and 90-95% have at least one transfusion, and those transfused received an average of 5 transfusions in their neonatal stay. Withholding milk feeds during red cell transfusion may reduce the risk of NEC by decreasing postprandial mesenteric ischemia but there may be harmful effects of pausing enteral feeds. However, due to a lack of good quality evidence, there is no consensus regarding the optimal feeding strategy during a blood transfusion. Both comparator pathways of care are standard practice in Canada and the UK; the WHEAT trial is a comparative effectiveness trial. The two care pathways that will be compared are: Withholding Feeds Around Transfusion: All enteral feeds will be discontinued (the infant will be placed nil by mouth) for 4 hours prior to packed red cell transfusion, during the packed red cell transfusion and until 4 hours post packed red cell transfusion. Continuing Feeds Around Transfusion: Enteral feeds will continue to be given prior, during and after the packed red cell transfusion, in the manner in which they were being given prior to the decision to transfuse. Infants will remain allocated to the same care pathway until 34(+6) weeks(+days) gestational age.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Necrotizing Enterocolitis
Keywords
Comparative Effectiveness Trial, Necrotizing Enterocolitis, Premature Infants, Blood Transfusion, Withholding enteral feeds

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The WHEAT trial is a pragmatic, randomized, controlled, unblinded, international, multicentre, parallel-group superiority trial comparing two clinical care pathways.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
4333 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Withholding feeds around transfusion
Arm Type
Active Comparator
Arm Description
All enteral feeds will be discontinued (the infant will be placed nil by mouth) for 4 hours prior to packed red cell transfusion, during the transfusion and until 4 hours post transfusion. During this period, hydration and blood glucose will be maintained according to local practice, commonly by providing parenteral nutrition or intravenous dextrose. Four hours after the red cell transfusion has finished, feeds will be recommenced to how they were being received prior to the decision to transfuse. This duration of withholding feeds will follow the approach used in other trials and observational studies, and identified as the most acceptable in a survey of UK neonatal units. It gives time for milk in the small bowel to transit into the large bowel before the transfusion and for the circulation to stabilize after the transfusion before milk feeds given into the stomach pass through into the small intestine.
Arm Title
Continuing feeds around transfusion
Arm Type
Active Comparator
Arm Description
Enteral feeds will continue to be given prior, during and after the packed red cell transfusion, in the manner in which they were being given prior to the decision to transfuse. Infants will remain allocated to the same care pathway until 34(+6) weeks(+days) gestational age.
Intervention Type
Other
Intervention Name(s)
Withholding feeds around transfusion
Intervention Description
Withholding enteral feeds for preterm infants (<30 weeks) around the time of blood transfusions to determine if any impact on the development and/or severity of Necrotizing Enterocolitis.
Intervention Type
Other
Intervention Name(s)
Continued feeds around transfusion
Intervention Description
Continued enteral feeds
Primary Outcome Measure Information:
Title
NEC Stage II
Description
NEC stage II or more after the first transfusion (modified Bell staging criteria) - Clinical signs and symptoms plus pneumatosis or portal/hepatic air diagnosed by x-ray or other imaging techniques
Time Frame
From randomization to 40 weeks postmenstrual age
Secondary Outcome Measure Information:
Title
Severe NEC
Description
Histologically or surgically confirmed or recorded on the death certificate. These infants will be identified as described in Battersby et al. which will include infants recorded as being transferred for surgery.
Time Frame
From randomization to 40 weeks postmenstrual age
Title
Death
Description
All-cause mortality
Time Frame
From randomization to 40 weeks postmenstrual age
Title
Late onset sepsis
Description
Culture positive sepsis, onset after 72 hours of life
Time Frame
From randomization to 40 weeks postmenstrual age
Title
Number of days with a central venous line in situ
Description
Number of days with a central venous line in situ
Time Frame
From birth to date of discharge home
Title
Number of central line associated bloodstream infections
Description
Includes laboratory-confirmed bloodstream infection and clinical sepsis
Time Frame
From randomization to 40 weeks postmenstrual age
Title
Duration of any parenteral nutrition in days
Description
Duration of any parenteral nutrition in days
Time Frame
From birth to 40 weeks postmenstrual age
Title
Growth
Description
Weight and head circumference z score.
Time Frame
At date of discharge home
Title
Spontaneous Intestinal Perforation
Description
Histologically or surgically confirmed or recorded in the death certificate.
Time Frame
From randomization to 40 weeks postmenstrual age
Title
Duration of hospital stay
Description
Total duration of neonatal care in days including all levels of care (intensive care, high dependency care, special care and ordinary care)
Time Frame
From birth to date of discharge home
Title
Bronchopulmonary Dysplasia (BPD)/Chronic Lung Disease
Description
Requiring respiratory support at 36 weeks gestation
Time Frame
At 36 weeks postmenstrual age
Title
Retinopathy of prematurity (ROP)
Description
ROP requiring treatment
Time Frame
From randomization to 40 weeks postmenstrual age
Title
Severe Brain Injury
Description
Intraventricular haemorrhage (IVH) grade 3 or 4 or cystic periventricular leukomalacia (PVL)
Time Frame
At 40 weeks postmenstrual age

10. Eligibility

Sex
All
Maximum Age & Unit of Time
30 Weeks
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 1. Preterm birth at <30+0 gestational weeks + days Exclusion Criteria: Parent(s) opt-out of trial participation. Packed red cell transfusion with concurrent enteral feeds prior to enrolment. (Infants who have received a packed red cell transfusion while nil-by-mouth are eligible; buccal colostrum will not be counted as enteral feeding). Infants where enteral feeding is contraindicated in the first 7 days after birth [e.g. Major congenital abnormality of the gastrointestinal tract (GIT)]. Previous episode of NEC or spontaneous intestinal perforation (SIP) prior to first packed cell transfusion.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Emily MacLeod
Phone
9024706679
Email
emily.macleod@iwk.nshealth.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Tara Hatfield
Phone
9024706630
Email
tara.hatfield@iwk.nshealth.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Balpreet Singh, MD
Organizational Affiliation
IWK Health, Canada
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jon Dorling, MD
Organizational Affiliation
Princess Anne Hospital, UK
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Chris Gale, MD
Organizational Affiliation
Imperial College London, UK
Official's Role
Principal Investigator
Facility Information:
Facility Name
IWK Health
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3K 6R8
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emily MacLeod
Phone
9024706679
Email
emily.macleod@iwk.nshealth.ca
First Name & Middle Initial & Last Name & Degree
Balpreet Singh, MD

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
28404014
Citation
Battersby C, Longford N, Mandalia S, Costeloe K, Modi N; UK Neonatal Collaborative Necrotising Enterocolitis (UKNC-NEC) study group. Incidence and enteral feed antecedents of severe neonatal necrotising enterocolitis across neonatal networks in England, 2012-13: a whole-population surveillance study. Lancet Gastroenterol Hepatol. 2017 Jan;2(1):43-51. doi: 10.1016/S2468-1253(16)30117-0. Epub 2016 Nov 8.
Results Reference
background
PubMed Identifier
20447649
Citation
Duro D, Kalish LA, Johnston P, Jaksic T, McCarthy M, Martin C, Dunn JC, Brandt M, Nobuhara KK, Sylvester KG, Moss RL, Duggan C. Risk factors for intestinal failure in infants with necrotizing enterocolitis: a Glaser Pediatric Research Network study. J Pediatr. 2010 Aug;157(2):203-208.e1. doi: 10.1016/j.jpeds.2010.02.023. Epub 2010 May 6.
Results Reference
background
PubMed Identifier
15741374
Citation
Hintz SR, Kendrick DE, Stoll BJ, Vohr BR, Fanaroff AA, Donovan EF, Poole WK, Blakely ML, Wright L, Higgins R; NICHD Neonatal Research Network. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics. 2005 Mar;115(3):696-703. doi: 10.1542/peds.2004-0569.
Results Reference
background
PubMed Identifier
16984980
Citation
Rees CM, Pierro A, Eaton S. Neurodevelopmental outcomes of neonates with medically and surgically treated necrotizing enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2007 May;92(3):F193-8. doi: 10.1136/adc.2006.099929. Epub 2006 Sep 19.
Results Reference
background
PubMed Identifier
24931684
Citation
Duley L, Uhm S, Oliver S; Preterm Birth Priority Setting Partnership Steering Group. Top 15 UK research priorities for preterm birth. Lancet. 2014 Jun 14;383(9934):2041-2042. doi: 10.1016/S0140-6736(14)60989-2. No abstract available.
Results Reference
background
PubMed Identifier
6279816
Citation
Seges RA, Kenny A, Bird GW, Wingham J, Baals H, Stauffer UG. Pediatric surgical patients with severe anaerobic infection: report of 16 T-antigen positive cases and possible hazards of blood transfusion. J Pediatr Surg. 1981 Dec;16(6):905-10. doi: 10.1016/s0022-3468(81)80844-5.
Results Reference
background
PubMed Identifier
22447991
Citation
Stritzke AI, Smyth J, Synnes A, Lee SK, Shah PS. Transfusion-associated necrotising enterocolitis in neonates. Arch Dis Child Fetal Neonatal Ed. 2013 Jan;98(1):F10-4. doi: 10.1136/fetalneonatal-2011-301282. Epub 2012 Mar 23.
Results Reference
background
PubMed Identifier
21067771
Citation
Blau J, Calo JM, Dozor D, Sutton M, Alpan G, La Gamma EF. Transfusion-related acute gut injury: necrotizing enterocolitis in very low birth weight neonates after packed red blood cell transfusion. J Pediatr. 2011 Mar;158(3):403-9. doi: 10.1016/j.jpeds.2010.09.015. Epub 2010 Nov 10.
Results Reference
background
PubMed Identifier
17009195
Citation
Mally P, Golombek SG, Mishra R, Nigam S, Mohandas K, Depalhma H, LaGamma EF. Association of necrotizing enterocolitis with elective packed red blood cell transfusions in stable, growing, premature neonates. Am J Perinatol. 2006 Nov;23(8):451-8. doi: 10.1055/s-2006-951300. Epub 2006 Sep 28.
Results Reference
background
PubMed Identifier
28601308
Citation
Cunningham KE, Okolo FC, Baker R, Mollen KP, Good M. Red blood cell transfusion in premature infants leads to worse necrotizing enterocolitis outcomes. J Surg Res. 2017 Jun 1;213:158-165. doi: 10.1016/j.jss.2017.02.029. Epub 2017 Feb 28.
Results Reference
background
PubMed Identifier
25652740
Citation
Keir AK, Yang J, Harrison A, Pelausa E, Shah PS; Canadian Neonatal Network. Temporal changes in blood product usage in preterm neonates born at less than 30 weeks' gestation in Canada. Transfusion. 2015 Jun;55(6):1340-6. doi: 10.1111/trf.12998. Epub 2015 Feb 5. Erratum In: Transfusion. 2015 Sep;55(9):2295.
Results Reference
background
PubMed Identifier
16939737
Citation
Kirpalani H, Whyte RK, Andersen C, Asztalos EV, Heddle N, Blajchman MA, Peliowski A, Rios A, LaCorte M, Connelly R, Barrington K, Roberts RS. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006 Sep;149(3):301-307. doi: 10.1016/j.jpeds.2006.05.011.
Results Reference
background
PubMed Identifier
28916576
Citation
Jasani B, Rao S, Patole S. Withholding Feeds and Transfusion-Associated Necrotizing Enterocolitis in Preterm Infants: A Systematic Review. Adv Nutr. 2017 Sep 15;8(5):764-769. doi: 10.3945/an.117.015818. Print 2017 Sep.
Results Reference
background
PubMed Identifier
30890001
Citation
Sahin S, Gozde Kanmaz Kutman H, Bozkurt O, Yavanoglu Atay F, Emre Canpolat F, Uras N, Suna Oguz S, Underwood MA. Effect of withholding feeds on transfusion-related acute gut injury in preterm infants: a pilot randomized controlled trial. J Matern Fetal Neonatal Med. 2020 Dec;33(24):4139-4144. doi: 10.1080/14767058.2019.1597844. Epub 2019 Mar 28.
Results Reference
background
PubMed Identifier
8614608
Citation
Neu J. Necrotizing enterocolitis: the search for a unifying pathogenic theory leading to prevention. Pediatr Clin North Am. 1996 Apr;43(2):409-32. doi: 10.1016/s0031-3955(05)70413-2.
Results Reference
background
PubMed Identifier
28046187
Citation
Battersby C, Longford N, Costeloe K, Modi N; UK Neonatal Collaborative Necrotising Enterocolitis Study Group. Development of a Gestational Age-Specific Case Definition for Neonatal Necrotizing Enterocolitis. JAMA Pediatr. 2017 Mar 1;171(3):256-263. doi: 10.1001/jamapediatrics.2016.3633. Erratum In: JAMA Pediatr. 2017 Jul 1;171(7):712.
Results Reference
background

Learn more about this trial

WithHolding Enteral Feeds Around Blood Transfusion (International)

We'll reach out to this number within 24 hrs